Cannabis News
Market-moving headlines, earnings, and regulatory shifts across the cannabis sector
Track the developments that move cannabis stocks — from quarterly earnings and M&A deals to state-level legalization votes and federal policy changes. Articles are tagged with relevant stock tickers so you can see which companies are affected and jump straight to their market data.
ASX Cannabis Stocks Draw Fresh Capital as Risk Appetite Returns
Australian cannabis equities attract renewed investor interest amid broader market recovery, signaling potential sector rotation into beaten-down marijuana assets.
Lifeist Wellness Surges 24.5% on Elevated Volume Despite Penny Stock Status
LFSWF climbed to $0.03 on 10,645 shares traded, representing a significant move for the micro-cap wellness company.
GCAN Plummets 36% as Cannabis Stock Hits Near 52-Week Low
Greater Cannabis Company shares crashed 36.1% to $0.12, bringing the MSO's market cap to just $100,000 amid ongoing sector pressures.
Cannabis Tourism Drives New Revenue Streams for Outdoor Recreation
Emerging cannabis camping trend creates untapped market opportunities as outdoor enthusiasts integrate consumption with recreational activities.
Export Quality Standards Drive Cannabis Stock Performance Divergence
Quality control requirements for international cannabis exports create new investment criteria as institutional capital flows toward compliant operators.
Cannabis Sector Tests Investor Patience Amid Execution Challenges
Cannabis equities face mounting pressure to deliver operational results as market enthusiasm wanes and investors demand concrete performance metrics.
States Launch Probes Into Cannabis Emergency Room Visits
Multiple state health departments initiate investigations into rising cannabis-related hospital admissions, potentially impacting regulatory frameworks.
Curaleaf Explores Share Restructuring for Major Index Inclusion
Multi-state operator examines strategic options to meet Russell 1000 requirements as cannabis sector eyes mainstream institutional access.
Cannabis Sector Divergence: Selective Buying Emerges Amid Broader Retreat
Market shows signs of stock-picking as some cannabis names attract buyers while sector indices continue downward pressure across major operators.
Australian Cannabis Stocks Enter Performance-Driven Era
ASX-listed cannabis companies face investor scrutiny as speculation gives way to fundamental analysis and operational results in 2026.
Australian Cannabis Exporters Target International Medical Markets
ASX-listed cannabis companies pivot to global medical exports as domestic market constraints drive international expansion strategies.
Cannabis Rescheduling Timeline Remains Murky as Industry Awaits Clarity
Federal rescheduling process creates uncertainty for cannabis operators as regulatory timeline stretches into 2025, impacting investment flows and strategic planning.
Cannabis Healthcare Stocks Rally as Medical Adoption Accelerates
Medical cannabis companies surge as healthcare integration drives institutional investment and patient access expands nationwide.
Cannabis Insurance Disruption Creates New Investment Opportunities
Specialized insurance providers serving cannabis businesses emerge as unexpected winners, delivering outsized returns as regulatory barriers create market gaps.
Alabama Medical Cannabis Sales Hit 100+ Patients in Launch Week
Alabama's medical marijuana program sees strong early adoption with over 100 patient purchases, signaling another state market coming online for cannabis operators.
Alabama Medical Cannabis Sales Launch: 100+ Patients Served in Week One
Alabama's inaugural medical cannabis dispensary serves over 100 patients in first week, marking another state's entry into the expanding U.S. medical marijuana market.
Gray Market Psychedelics Surge as Regulatory Gaps Create New Revenue Streams
Unregulated psychedelic products flood consumer markets while traditional cannabis operators eye expansion opportunities in emerging sector worth billions.
Canopy Growth Earnings Preview: Cannabis Giant Faces Critical Quarter
CGC reports quarterly results amid sector volatility and restructuring efforts. Investors watch for revenue trends and path to profitability signals.
NYSE Lists First US Cannabis Stock in Historic Market Milestone
A US marijuana company breaks barriers by securing NYSE listing, potentially opening institutional investment floodgates for the cannabis sector.
NYSE Welcomes First US Cannabis Stock in Historic Market Milestone
A US cannabis company achieves NYSE listing, marking a watershed moment that could reshape institutional access and legitimacy for the entire sector.